Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma
Pathology · 2025
DOI: 10.1016/j.pathol.2024.08.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology, 2025. Verfasst von Ying Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatectomy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
- Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA; Department of Urology, University of Rochester Medical Center, Rochester, NY, USA; James P. Wilmot Cancer Instit…
Zitieren
APA
Wang, Y., Teramoto, Y., & Miyamoto, H. (2025). Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma. Pathology. https://doi.org/10.1016/j.pathol.2024.08.012
Vancouver
Wang Y, Teramoto Y, Miyamoto H. Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma. Pathology. 2025. doi:10.1016/j.pathol.2024.08.012
BibTeX
@article{Wang2025,
author = {Wang, Ying and Teramoto, Yuki and Miyamoto, Hiroshi},
title = {Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma},
journal = {Pathology},
year = {2025},
doi = {10.1016/j.pathol.2024.08.012}
}
EUVIMED